TMCnet

InterVenn Biosciences and Aranscia Expand Commercialization Partnership for GlycoKnow™ Ovarian Cancer Diagnostic Test

InterVenn Biosciences, a life sciences company unlocking the value of glycoproteomics for the development of transformational healthcare solutions, and Aranscia, a global provider of award-winning ...
JD Supra

FDA’s Proposed Rule for Oversight of Laboratory Developed Tests: Part II: FDA’s Proposed Phaseout Policy - Key Considerations & Open Questions

After an over decade-long discourse amongst interested stakeholders, on October 3, 2023, FDA unveiled its proposed rule and policy to increase oversight over LDTs. If finalized as proposed, FDA would ...

Evexia Diagnostics Expands At-Home Testing Capabilities with the Addition of Biobox™ by Access Labs

New at-home blood collection solution helps clinicians increase patient compliance, expand access to testing, and ...

Legacy Receives New York State CLEP Approval For Two Laboratory-Developed Tests: Semen Analysis And DNA Fragmentation

Legacy Receives New York State CLEP Approval For Two Laboratory-Developed Tests: Semen Analysis And DNA Fragmentation. Legacy clears New York's stringent pre-market review of laboratory-developed ...
Labroots

Facing Multi-Residue Complexity? Rethink Your Food Testing Workflow with the Thermo Scientific EFOX analytical solutions platform

Food testing laboratories are facing increasing pressure to deliver fast, reliable, and defensible results across complex matrices. Expanding pesticide panels, stricter regulatory expectations, and ...